DXCM vs ULY · P/E 63, rev $2.50B vs rev $142.9M
DexCom Inc (DXCM) versus Urgent.ly Inc. Common Stock (ULY) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Urgent.ly Inc. Common Stock (ULY) is a software - application company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported ULY revenue for 2024-12-31 was $142.9M. Net income was -$44.0M. Revenue was down 22.6% from 2023-12-31 to 2024-12-31. ULY currently screens at market cap $9.3M.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. ULY currently screens at market cap $9.3M.
Not investment advice. Open the DXCM and ULY stock pages for the full models.
Not investment advice.